American Journal of Clinical Dermatology

Papers
(The TQCC of American Journal of Clinical Dermatology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative226
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions169
The Current State of Systemic Therapy of Metastatic Uveal Melanoma113
Prognostic Biomarkers in Evolving Melanoma Immunotherapy99
Economic Burden of Chronic Hand Eczema: A Review97
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments90
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review89
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review88
The Burden of Pediatric Psoriasis: A Systematic Review83
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments81
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma67
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials62
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study62
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution61
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know61
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review60
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?60
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology60
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks58
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data57
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi55
Pathophysiology of Generalized Pustular Psoriasis55
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation53
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion53
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study52
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”51
Skin Cancer in People of Color: A Systematic Review47
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment47
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials45
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission44
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry44
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature43
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review42
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis42
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management41
A Practice Approach to Acne Fulminans in Adolescents40
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives40
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment40
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist39
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis39
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm38
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis38
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review36
Patient and Public Involvement in Dermatology Research: A Review36
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates36
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching35
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa34
Oral Lichen Planus: An Update on Diagnosis and Management34
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases34
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”33
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada32
Frontal Fibrosing Alopecia: An Update30
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review30
Individualized Neoantigen-Directed Melanoma Therapy29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists29
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study28
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials28
Advancing Precision Medicine in Inflammatory Skin Disease28
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential27
Targeting Inflammation in Acne: Current Treatments and Future Prospects27
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History27
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)27
Acknowledgement to Referees26
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients26
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”26
Approach to the Atypical Wound25
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review25
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results24
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study24
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians24
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management24
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis24
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea24
Management of Acne in Pregnancy23
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year23
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management23
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey23
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 22
Is There a Place for Biologics in Acne?22
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study22
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts21
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials21
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights21
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)21
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color20
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study20
Safety of Hydroxychloroquine: What a Dermatologist Should Know20
0.31384921073914